Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
Clinical trial NCT00133900 · UNKNOWN
Trial details
- NCT number
- NCT00133900
- Sponsor
- Immunicon
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2004-12-01
- Primary completion
- 2009-02-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.